Brull, D.J., Montgomery, H.E., Sanders, J., Dhamrait, S., Luong, L., Rumley, A., et al. (2001) Interleukin-6 Gene ﹣174G > C and ﹣572G > C Promoter Polymorphisms Are Strong Predictors of Plasma Interleukin-6 Levels after Coronary Artery Bypass Surgery. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 1458-1463.
http://dx.doi.org/10.1161/hq0901.094280

has been cited by the following article:

• TITLE: Clinical Implications of Tumor Necrosis Factor-Alpha, Interleukin-6 and Resistin in Coronary Artery Disease

  AUTHORS: Qamar Javed

  KEYWORDS: Tumor Necrosis Factor-Alpha, Interleukin-6, Resistin, Coronory Heart Disease, Gene Polymorphism

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.4 No.9, August 19, 2014

  ABSTRACT: Tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) are involved in the progression of coronary artery disease (CAD). The cytokines’ levels are associated with the severity of CAD. We have recently reported on the association of resistin, a relatively novel cytokine with the pathogenesis of cardiovascular disease (CVD). Although the inflammatory cytokines’ impact on atherosclerosis is widely accepted, yet some controversy exists regarding the involvement of these factors in atherogenesis. The current review highlights the potential association of TNF-alpha, IL-6 and resistin SNPs (single nucleotide polymorphisms) with CAD. Molecular genetics data along with the intracellular signaling cascade mechanisms may have important clinical implications in the treatment of CAD.